Clinical Non-inferiority Study Between Diosmin 600mg & Diosmin + Hesperidin in Symptomatic Chronic Venous Insufficiency
Status:
Completed
Trial end date:
2018-04-30
Target enrollment:
Participant gender:
Summary
Clinical non-inferiority study between Diosmin 600 mg tablets and Diosmin 900 mg + Hesperidin
100 mg tablets in symptomatic chronic venous insufficiency after 6 months of treatment.
Prospective, single-blind, randomized study in parallel groups (total patient population 120,
60 subjects per treatment group), with a total of 4 clinical assessment at months 0, 2, 4,
and 6 of treatment.